
Teva’s CEO shares ‘Pivot to Growth’ progress
The Top Line
00:00
Innovative Advances in IBD Treatment
This chapter explores groundbreaking developments in a new medicine targeting inflammatory bowel disease, presenting its promising phase two results and market potential. Additionally, it highlights the pharmaceutical company's pipeline assets, collaborations, and emerging oncology treatments, showcasing a commitment to address chronic conditions effectively.
Transcript
Play full episode